UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
New virus cases rebound amid rise of local infections
Korea's new Covid-19 cases rose above 40 on Wednesday, as local infecti...
by Shim Hyun-tai
|
2020-08-06 12:33
라인
Celltrion, Incheon to create global bio innovation cluster
Celltrion said Wednesday that it has signed an agreement with Incheon Metro...
by Shim Hyun-tai
|
2020-08-05 18:03
라인
Hanmi, MSD sign licensing agreement for hepatitis treatment
Hanmi Pharmaceutical said it has entered into an exclusive licensing agreem...
by Shim Hyun-tai
|
2020-08-05 15:24
라인
GCMS wins regulatory nod to export rapid Covid-19 test kit
GC Medical Science (GCMS) on Monday won permit from the Ministry of Food an...
by Shim Hyun-tai
|
2020-08-04 17:33
라인
Regulator temporarily bans sales of 62 Medtronic’s products
The Korea Ministry of Food and Drug Safety (MFDS) said Tuesday that it temp...
by Shim Hyun-tai
|
2020-08-04 17:10
라인
New virus cases rebound due to continuous imported infections
Korea’s new Covid-19 cases rose above 30 on Monday amid sporadic community ...
by Shim Hyun-tai
|
2020-08-04 13:46
라인
KAIST develops deep learning-based ‘cough-recognizing’ camera
A research institute-business enterprise joint team has developed a camera ...
by Shim Hyun-tai
|
2020-08-03 17:53
라인
Medpacto to develop test kit for metastatic breast cancer
MedPacto, a biomarker-based cancer drug developer, and medical equipment ma...
by Shim Hyun-tai
|
2020-08-03 17:51
라인
AbbVie’s hepatitis C drug Maviret gets expanded regulatory nod
AbbVie received the local regulatory approval on July 31 to shorten the tre...
by Shim Hyun-tai
|
2020-08-03 17:51
라인
Korean medical firms win export contracts of $9 million in China
Korean medical equipment and cosmetics makers garnered export contracts of ...
by Shim Hyun-tai
|
2020-07-24 18:18
라인
KUAH wins 1st-grade stroke adequacy assessment for 8th straight time
Korea University Ansan Hospital (KUAH) has won the highest grade in the acu...
by Shim Hyun-tai
|
2020-07-24 18:18
라인
Yonsei researchers develop model to predict dementia in Parkinson’s disease patients
Researchers at Yonsei University College of Medicine said Thursday that the...
by Shim Hyun-tai
|
2020-07-23 17:57
라인
Regulator OKs Keytruda for head and neck cancer therapy
MSD Korea said that it has won expanded indication for its cancer immunothe...
by Shim Hyun-tai
|
2020-07-23 17:57
라인
CHA Hospital finds why specific ovarian cancer recurs and spreads
A research team at Bundang CHA Hospital has found the mechanism of recurrin...
by Shim Hyun-tai
|
2020-07-23 15:21
라인
Community infections hit 2-week high
Korea’s new Covid-19 cases jumped back above 60 on Tuesday, as local infect...
by Shim Hyun-tai
|
2020-07-22 12:15
라인
‘Inhaling luminous agent helps observe lung cancer interface’
The National Research Foundation of Korea said Tuesday that a joint researc...
by Shim Hyun-tai
|
2020-07-21 18:33
라인
'Ethnic differences affect optimal care path for inflammatory bowel disease'
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Cro...
by Shim Hyun-tai
|
2020-07-21 17:40
라인
GC LabCell’s tech wins patent for delivering gene therapy to brain
GC Labcell said Tuesday that it obtained a domestic patent for a compositio...
by Shim Hyun-tai
|
2020-07-21 15:52
라인
KUAH researchers develop tech on stem cells for leukemia patients
A research team of Korea University Anam Hospital (KUAH) has recently succe...
by Shim Hyun-tai
|
2020-07-20 21:28
라인
GC makes plasma Covid-19 therapy for clinical trials
GC Pharma has taken the first step to commercialize its new plasma treatmen...
by Shim Hyun-tai
|
2020-07-20 17:30
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top